EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Elevated levels of interleukin‐33 are associated with asthma: A meta‐analysis

Ranran Zhao, Yun Shi iD, Na Liu, Bin Li

Immunity, Inflammation and Disease · 2023-04 · 11 (4)

DOI: 10.1002/iid3.842 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 19.04.2023. Verfasst von Ranran Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, China. Hauptthemen laut MEDLINE: Interleukin-33, Asthma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous studies reported that patients with asthma showed higher levels of interleukin (IL)‐33 in peripheral blood, compared to healthy control (HCs). However, we also noticed that there were no significant differences of IL‐33 levels between controls and asthma patients in a recent study. We aim to conduct this meta‐analysis and evaluate the feasibility of IL‐33 in peripheral blood that may act as a promising biomarker in asthma.

Methods

Articles published before December 2022 were searched in these databases (PubMed, Web of Science, EMBASE, and Google Scholar). We used STATA 12.0 software to compute the results.

Results

The study showed that asthmatics showed higher IL‐33 level in serum and plasma, compared to HCs (serum: standard mean difference [SMD] 2.06, 95% confidence interval [CI] 1.12−3.00, I 2 = 98.4%, p < .001; plasma: SMD 3.67, 95% CI 2.32−5.03, I 2 = 86.0%, p < .001). Subgroup analysis indicated that asthma adults showed higher IL‐33 level in serum, compared to HCs, whereas no significant difference in IL‐33 level in serum was showed between asthma children and HCs (adults: SMD 2.17, 95% CI 1.09−3.25; children: SMD 1.81, 95% CI −0.11 to 3.74). The study indicated that moderate and severe asthmatics showed higher IL‐33 level in serum, compared to mild asthmatics (SMD 0.78, 95% CI 0.41−1.16, I 2 = 66.2%, p = .011).

Conclusions

In conclusion, the main findings of present meta‐analysis suggested that there was a significant correlation between IL‐33 levels and the severity of asthma. Therefore, IL‐33 levels of either serum or plasma may be regarded as a useful biomarker of asthma or the degree of disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-33AsthmaAdultChildHumansBiomarkersCase-Control Studies

Stichwörter der Autor:innen

asthmainterleukin-33meta-analysisserumsystematic review

Substanzen

Interleukin-33Biomarkers

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, China.
  • Medical and Health Center, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, China.
  • Department of Respiratory Medicine, Beijing Hepingli hospital, Beijing, China.

ORCID-Profile: Yun Shi

Zitieren

APA

Zhao, R., Shi, Y., Liu, N., & Li, B. (2023). Elevated levels of interleukin‐33 are associated with asthma: A meta‐analysis. Immunity, Inflammation and Disease, 11(4). https://doi.org/10.1002/iid3.842

Vancouver

Zhao R, Shi Y, Liu N, Li B. Elevated levels of interleukin‐33 are associated with asthma: A meta‐analysis. Immunity, Inflammation and Disease. 2023;11(4). doi:10.1002/iid3.842

BibTeX
@article{Zhao2023,
  author = {Zhao, Ranran and Shi, Yun and Liu, Na and Li, Bin},
  title = {Elevated levels of interleukin‐33 are associated with asthma: A meta‐analysis},
  journal = {Immunity, Inflammation and Disease},
  year = {2023},
  volume = {11},
  number = {4},
  doi = {10.1002/iid3.842}
}
Kostenlos starten →